摘要
阿兹海默症相关的病理学结果显示大脑有极大的结构及功能性改变。这些形态学的改变将可能导致大脑自动分割算法在阿兹海默症患者中精确性降低,进而可能导致灰质、白质或脑脊髓液的错误分割。FreeSurfer系统已被证实,在对神经解剖学结构里皮质层厚度和容积的测量中,是精确及可信赖的工具。考虑到AD的成像领域中Freesurfer系统的主要作用,本研究旨在探索FreeSurfer系统对于捕获大脑针对不同处理变量中形态学改变的鲁棒性并与人工测量(金标准)相比较。53人进行T1加权MRI扫描(18名健康人,18名轻度认知功能障碍者,和18名轻度AD患者)。在定制系统(LINUX)和Mac(UNIX)工作站使用不同的FreeSurfer版本(v4.3.1,v4.5.0、v5.0.0、v5.1.0)进行数据分析。疾病早期阶段的已知影响区域中,海马体和后扣带在版本和工作站的组间差异最一致。结果显示FreeSurfer系统的新版本辨别组间差异更敏感并与金标准人工容积测定方法的最佳结果相一致。总之,FreeSurfer系统的新版本比早期版本更精确,特别在内侧颞叶和后顶叶区域。此发展对FreeSurfer系统运用于调查研究中很有前景,并激励了FreeSurfer系统作为临床实践中候选标记输出的未来角色。
关键词: 阿兹海默症,早期认知功能障碍,MRI,成像,自动分割,FreeSurfer。
Current Alzheimer Research
Title:Can FreeSurfer Compete with Manual Volumetric Measurements in Alzheimer’s Disease?
Volume: 12 Issue: 4
Author(s): Lies Clerx, Ed H.B.M. Gronenschild, Carmen Echavarri, FransVerhey, Pauline Aalten and Heidi I.L. Jacobs
Affiliation:
关键词: 阿兹海默症,早期认知功能障碍,MRI,成像,自动分割,FreeSurfer。
摘要: Alzheimer’s disease-related pathology results in tremendous structural and functional changes in the brain. These morphological changes might lead to a less precise performance of automated brain segmentation techniques in AD-patients, which in turn could possibly lead to false allocations of gray matter, white matter or cerebrospinal fluid. FreeSurfer has been shown to operate as an accurate and reliable instrument to measure cortical thickness and volume of neuroanatomical structures. Considering the principal role of FreeSurfer in the imaging field of AD, the present study aims to investigate the robustness of FreeSurfer to capture morphological changes in the brain against varying processing variables in comparison to manual measurements (the gold standard). T1-weighted MRI scan data were used pertaining to a sample of 53 individuals (18 healthy participants, 18 patients with mild cognitive impairment, and 18 patients with mild AD). Data were analyzed with different FreeSurfer versions (v4.3.1, v4.5.0, v5.0.0, v5.1.0), on a custom-built cluster (LINUX) and a Macintosh (UNIX) workstation. Group differences across versions and workstations were most consistent for both the hippocampus and posterior cingulate, regions known to be affected in the earliest stages of the disease. The results showed that later versions of FreeSurfer were more sensitive to identify group differences and corresponded best with the results of gold standard manual volumetric methods. In conclusion, later versions of FreeSurfer were more accurate than earlier versions, especially in medial temporal and posterior parietal regions. This development is very promising for future applications of FreeSurfer in research studies and encourages the future role of FreeSurfer output as a candidate marker in clinical practice.
Export Options
About this article
Cite this article as:
Lies Clerx, Ed H.B.M. Gronenschild, Carmen Echavarri, FransVerhey, Pauline Aalten and Heidi I.L. Jacobs , Can FreeSurfer Compete with Manual Volumetric Measurements in Alzheimer’s Disease?, Current Alzheimer Research 2015; 12 (4) . https://dx.doi.org/10.2174/1567205012666150324174813
DOI https://dx.doi.org/10.2174/1567205012666150324174813 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity
Current HIV Research Vasculogenic and Angiogenic Pathways in Moyamoya Disease
Current Medicinal Chemistry The Neurovascular Unit: Focus on the Regulation of Arterial Smooth Muscle Cells
Current Neurovascular Research Citalopram-Associated Alopecia: A Case Report and Brief Literature Review
Current Drug Safety Methodologies to Assess Brain Drug Delivery in Lead Optimization
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets CGRP-Receptor Antagonism in Migraine Treatment
CNS & Neurological Disorders - Drug Targets Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
Current Drug Targets The Endocannabinoid System and Schizophrenia: Integration of Evidence
Current Pharmaceutical Design Positron Emission Tomography in Neuroimaging - An Update
Current Medical Imaging The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease
Current Topics in Medicinal Chemistry Elucidating the Risk Factors for Progression from Amyloid-Negative Amnestic Mild Cognitive Impairment to Dementia
Current Alzheimer Research Oxidative Stress and Post-Stroke Depression: Possible Therapeutic Role of Polyphenols?
Current Medicinal Chemistry β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Current Pharmaceutical Design The Molecular Pathology of Huntingtons Disease (HD)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Lifelong Endocrine Fluctuations and Related Cognitive Disorders
Current Pharmaceutical Design Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Current Protein & Peptide Science The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer’s Disease
Current Pharmaceutical Design Editorial (Thematic Issue: Neuroglia in Alzheimer’s Disease: From Cohort to Contestant in the Disease Progression and its Therapy)
Current Alzheimer Research HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET
Current Drug Targets